Prediction of newly developed acute renal failure using serum phosphorus concentrations after living-donor liver transplantation

Journal of International Medical Research

Volumn 40, Issue 6, 2012, Pages 2199-2212

  Hong, S H ^a   Park, C O ^a   Park, C S ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

Acute renal failure; Graft dysfunction; Hyperphosphataemia; Living donor liver transplantation; Postoperative mortality; Serum phosphorus

Indexed keywords

BASILIXIMAB; BICARBONATE; CALCIUM CHLORIDE; CREATININE; CYCLOSPORIN; FUROSEMIDE; LACTIC ACID; PHOSPHORUS; PREDNISOLONE; TACROLIMUS;

ACUTE KIDNEY FAILURE; ADULT; ARTICLE; CLINICAL ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG DOSE REDUCTION; ERYTHROCYTE TRANSFUSION; FEMALE; GLOMERULUS FILTRATION RATE; GRAFT DYSFUNCTION; HUMAN; HYPERPHOSPHATEMIA; HYPOCALCEMIA; INTENSIVE CARE UNIT; LENGTH OF STAY; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; LIVING DONOR; MALE; METABOLIC ACIDOSIS; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; OLIGURIA; PHOSPHATE BLOOD LEVEL; POSTOPERATIVE PERIOD; PREDICTION; PREOPERATIVE EVALUATION; RENAL REPLACEMENT THERAPY; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; RISK INJURY FAILURE LOSS END-STAGE KIDNEY DISEASE; SURGICAL MORTALITY;

EID: 84872225170     PISSN: 03000605     EISSN: 14732300     Source Type: Journal    
DOI: 10.1177/030006051204000618     Document Type: Article

References (44)

1. Nadim MK, Genyk YS, Tokin C, et al: Impact of the etiology of acute kidney injury on outcomes following liver transplantation: acute tubular necrosis versus hepatorenal syndrome. Liver Transpl 2012; 18: 539-548.
2. Lima EQ, Zanetta DM, Castro I, et al: Risk factors for development of acute renal failure after liver transplantation. Ren Fail 2003; 25: 553-560.
3. Bilbao I, Charco R, Balsells J, et al: Risk factors for acute renal failure requiring dialysis after liver transplantation. Clin Transplant 1998; 12: 123-129.
4. McCauley J, Van Thiel DH, Starzl TE, et al: Acute and chronic renal failure in liver transplantation. Nephron 1990; 55: 121-128.
5. Barri YM, Sanchez EQ, Jennings LW, et al: Acute kidney injury following liver transplantation: definition and outcome. Liver Transpl 2009; 15: 475-483.
6. Zhu M, Li Y, Xia Q, et al: Strong impact of acute kidney injury on survival after liver transplantation. Transplant Proc 2010; 42: 3634-3638.
7. Smith JO, Shiffman ML, Behnke M, et al: Incidence of prolonged length of stay after orthotopic liver transplantation and its influence on outcomes. Liver Transpl 2009; 15: 273-279.
8. Pawarode A, Fine DM, Thuluvath PJ: Independent risk factors and natural history of renal dysfunction in liver transplant recipients. Liver Transpl 2003; 9: 741-747.
9. Xu X, Ling Q, Wei Q, et al: An effective model for predicting acute kidney injury after liver transplantation. Hepatobiliary Pancreat Dis Int 2010; 9: 259-263.
10. Lima EQ, Zanetta DM, Castro I, et al: Risk factors for development of acute renal failure after liver transplantation. Ren Fail 2003; 25: 553-560.
11. Lebrón Gallardo M, Herrera Gutierrez ME, Seller Pérez G, et al: Risk factors for renal dysfunction in the postoperative course of liver transplant. Liver Transpl 2004; 10: 1379-1385.
12. Rueggeberg A, Boehm S, Napieralski F, et al: Development of a risk stratification model for predicting acute renal failure in orthotopic liver transplantation recipients. Anaesthesia 2008; 63: 1174-1180.
13. Pham PT, Pham PC, Wilkinson AH: Management of renal dysfunction in the liver transplant recipient. Curr Opin Organ Transplant 2009; 14: 231-239.
14. Wagener G, Minhaz M, Mattis FA, et al: Urinary neutrophil gelatinase-associated lipocalin as a marker of acute kidney injury after orthotopic liver transplantation. Nephrol Dial Transplant 2011; 26: 1717-1723.
15. Biancofiore G, Pucci L, Cerutti E, et al: Cystatin C as a marker of renal function immediatelyafter liver transplantation. Liver Transpl 2006; 12: 285-291.
16. Jeong TD, Kim S, Lee W, et al: Neutrophil gelatinase-associated lipocalin as an early biomarker of acute kidney injury in liver transplantation. Clin Transplant 2012; 26: 775-781.
17. Niemann CU, Walia A, Waldman J, et al: Acute kidney injury during liver transplantation as determined by neutrophil gelatinase-associated lipocalin. Liver Transpl 2009; 15: 1852-1860.
18. Yuan D, Wei YG, Chen K, et al: Hepatectomyrelated hypophosphatemia may predict donor liver dysfunction in live-donor liver transplantation. Transplant Proc 2010; 42: 4548-4551.
19. Lee HW, Suh KS, Kim J, et al: Hypophosphatemia after live donor right hepatectomy. Surgery 2008; 144: 448-453.
20. Datta HK, Malik M, Neely RD: Hepatic surgeryrelated hypophosphatemia. Clin Chim Acta 2007; 380: 13-23.
21. Salem RR, Tray K: Hepatic resection-related hypophosphatemia is of renal origin as manifested by isolated hyperphosphaturia. Ann Surg 2005; 241: 343-348.
22. Bellomo R, Ronco C, Kellum JA, et al: Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004; 8: R204-R212.
23. Wiesner RH, McDiarmid SV, Kamath PS, et al: MELD and PELD: application of survival models to liver allocation. Liver Transpl 2001; 7: 567-580.
24. Pugh RN, Murray-Lyon IM, Dawson JL, et al: Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973; 60: 646-649.
25. Leithead JA, MacKenzie SM, Ferguson JW, et al: Is estimated glomerular filtration rate superior to serum creatinine in predicting mortality on the waiting list for liver transplantation? Transpl Int 2011; 24: 482-488.
26. Olthoff KM, Kulik L, Samstein B, et al: Validation of a current definition of early allograft dysfunction in liver transplant recipients and analysis of risk factors. Liver Transpl 2010; 16: 943-949.
27. O'Riordan A, Wong V, McQuillan R, et al: Acute renal disease, as defined by the RIFLE criteria, post-liver transplantation. Am J Transplant 2007; 7: 168-176.
28. Bell M, Liljestam E, Granath F, et al: Optimal follow-up time after continuous renal replacement therapy in actual renal failure patients stratified with the RIFLE criteria. Nephrol Dial Transplant 2005; 20: 354-360.
29. Kuitunen A, Vento A, Suojaranta-Ylinen R, et al: Acute renal failure after cardiac surgery: evaluation of the RIFLE classification. Ann Thorac Surg 2006; 81: 542-546.
30. Guitard J, Cointault O, Kamar N, et al: Acute renal failure following liver transplantation with induction therapy. Clin Nephrol 2006; 65: 103-112.
31. Uchino S, Bellomo R, Goldsmith D, et al: An assessment of the RIFLE criteria for acute renal failure in hospitalized patients. Crit Care Med 2006; 34: 1913-1917.
32. Hwang S, Lee SG, Ahn CS, et al: An increase in deceased donor incidence alleviated the need for urgent adult living donor liver transplantation in a Korean high-volume center. Transplant Proc 2010; 42: 1497-1501.
33. Cabezuelo JB, Ramirez P, Acosta F et al: Does the standard vs piggyback surgical technique affect the development of early acute renal failure after orthotopic liver transplantation? Transplant Proc 2003; 35: 1913-1914.
34. Jassem W, Koo DD, Cerundolo L, et al: Cadaveric versus living-donor livers: differences in inflammatory markers after transplantation. Transplantation 2003; 76: 1599-1603.
35. Yap SC, Lee HT: Acute kidney injury and extrarenal organ dysfunction: new concepts and experimental evidence. Anesthesiology 2012; 116: 1139-1148.
36. Gaasbeek A, Meinders AE: Hypophosphatemia: an update on its etiology and treatment. Am J Med 2005; 118: 1094-1101.
37. Burak KW, Rosen CB, Fidler JL, et al: Hypophosphatemia after right hepatectomy forliving donor liver transplantation. Can J Gastroenterol 2004; 18: 729-733.
38. George R, Shiu MH: Hypophosphatemia after major hepatic resection. Surgery 1992; 111: 281-286.
39. Rowe PS, Kumagai Y, Gutierrez G, et al: MEPE has the properties of an osteoblastic phosphatonin and minhibin. Bone 2004; 34: 303-319.
40. Koo M, Sabaté A, Ramos E, et al: Factors related to renal dysfunction after liver transplantation in patients with normal preoperative function. Rev Esp Anestesiol Reanim 2006; 53: 538-544 [in Spanish, English abstract].
41. de Boer MT, Christensen MC, Asmussen M, et al: The impact of intraoperative transfusion of platelets and red blood cells on survival after liver transplantation. Anesth Analg 2008; 106: 32-44.
42. Ramos E, Dalmau A, Sabate A, et al: Intraoperative red blood cell transfusion in liver transplantation: influence on patient outcome, prediction of requirements, and measures to reduce them. Liver Transpl 2003; 9: 1320-1327.
43. Selzner M, Kashfi A, Cattral MS, et al: Live donor liver transplantation in high MELD score recipients. Ann Surg 2010; 251: 153-157.
44. Lee JP, Heo NJ, Joo KW, et al: Risk factors for consequent kidney impairment and differential impact of liver transplantation on renal function. Nephrol Dial Transplant 2010; 25: 2772-2785.